Literature DB >> 19775626

Skin toxicities of targeted therapies.

Siegfried Segaert1, Gabriela Chiritescu, Liesbeth Lemmens, Kristien Dumon, Eric Van Cutsem, Sabine Tejpar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19775626     DOI： 10.1016/S0959-8049(09)70044-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  18 in total

Review 1.  Current challenges for the early clinical development of anticancer drugs in the era of molecularly targeted agents.

Authors:  Christophe Le Tourneau; Véronique Diéras; Patricia Tresca; Wulfran Cacheux; Xavier Paoletti
Journal:  Target Oncol       Date:  2010-04-02       Impact factor: 4.493

Review 2.  New cast for a new era: preclinical cancer drug development revisited.

Authors:  Grit S Herter-Sprie; Andrew L Kung; Kwok-Kin Wong
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 3.  Folliculitis induced by EGFR inhibitors, preventive and curative efficacy of tetracyclines in the management and incidence rates according to the type of EGFR inhibitor administered: a systematic literature review.

Authors:  Jean-Baptiste Bachet; Lucie Peuvrel; Claude Bachmeyer; Ziad Reguiai; Pierre A Gourraud; Olivier Bouché; Marc Ychou; Rene J Bensadoun; Brigitte Dreno; Thierry André
Journal:  Oncologist       Date:  2012-03-16

Review 4.  [Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects].

Authors:  P A Gerber; B A Buhren; S Kürle; B Homey
Journal:  Hautarzt       Date:  2010-08       Impact factor: 0.751

5.  IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer.

Authors:  Felix Zwicker; Falk Roeder; Christian Thieke; Carmen Timke; Marc W Münter; Peter E Huber; Jürgen Debus
Journal:  Strahlenther Onkol       Date:  2010-12-23       Impact factor: 3.621

Review 6.  [Cutaneous side effects of targeted cancer drugs].

Authors:  J Below; B Homey; P A Gerber
Journal:  Hautarzt       Date:  2017-01       Impact factor: 0.751

7.  Sorafenib Induced Hand-Foot Skin Reaction at Low Dose.

Authors:  Vrutika H Shah; Bhagyashree B Supekar; Rajesh P Singh; Jayesh I Mukhi
Journal:  Indian Dermatol Online J       Date:  2020-09-19

Review 8.  Kinase inhibitors and monoclonal antibodies in oncology: clinical implications.

Authors:  Helen Gharwan; Hunter Groninger
Journal:  Nat Rev Clin Oncol       Date:  2015-12-31       Impact factor: 66.675

9.  Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib.

Authors:  Lokesh Jain; Tristan M Sissung; Romano Danesi; Elise C Kohn; William L Dahut; Shivaani Kummar; David Venzon; David Liewehr; Bevin C English; Caitlin E Baum; Robert Yarchoan; Giuseppe Giaccone; Jürgen Venitz; Douglas K Price; William D Figg
Journal:  J Exp Clin Cancer Res       Date:  2010-07-14

Review 10.  Molecular biomarkers of colorectal cancer: prognostic and predictive tools for clinical practice.

Authors:  Wei-qin Jiang; Fang-fang Fu; Yang-xia Li; Wei-bin Wang; Hao-hao Wang; Hai-ping Jiang; Li-song Teng
Journal:  J Zhejiang Univ Sci B       Date:  2012-09       Impact factor: 3.066
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.